[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"d6bb69fbb9bdcc70cd6361d582c21f76496f9059ce266505448589f349687ff6","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"d6bb69fbb9bdcc70cd6361d582c21f76496f9059ce266505448589f349687ff6","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"3c8cd4704d6b0eae28f9bc845b541a6edbd388ae2fa9ca0594bb1448a151a053","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"3c8cd4704d6b0eae28f9bc845b541a6edbd388ae2fa9ca0594bb1448a151a053","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"c39c1ea365adb3fe09080fc3122cc9e9f16445feb7086adf35801ea43fadf148","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"a927fceb457e83b8a67e70efd2c7fa553899367e856ef0c54c6058491ef6ebcf","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"44d57c366fe7659e5de3addb82044f3c683c482d7bf22cf1fa06d1062d007945","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"b5da449cabfb96dbb8a828005ab2574952747202d3ef23a9bb5561e712911ef4","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"4eb2867392372816824afae34e98285f2cbda2a583cf26fcde92887e932a78e2","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"d66e74eafeef533e62fef16b6c9e672692f906462c1cad10ff6654b7fc9f8837","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"1daa1f86683e15e7dbcc283cfd045b7d7aa74dc4684c0abbf15e274b1fc01572","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"58529c1bd32f3d138b4bc2eebc28404c179496dd312fc963bd50455ecf7762eb","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"5377f1ec47834dc8e3efba916bc739819da0da1433ffe348d990b4a8aeb7a1fa","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"9f7b0afa074cf92b96a6299a3a7be90f6bde3ef1579ccfd394b756a4bc5cf94b","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"ab12b0817c107e71cb33063656bc38410015b9558322d463a44602aebbeebee9","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"a5fd35815e0ab58614c16677d50c9e25235f466a5e4c0bc82134be6705c97fff","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"215ed7346b37162883bd01c4d35c9ec6674ee3b2616125dbbe2b3392fd5a7a97","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"b0cd003e636ca5f77b4a4ceaf8f14b09f8f82aee2d047a1df61eabfc0aaf812a","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"c1987a053ecb0a8840dca6db5f34753a6c853e06f1bd2b814eba1c4d016b06e5","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"32a146f7d8d2639467aa25df54722b0d324a68c428dc3cf325e9588489f7bcf8","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"f1893e3cfccf735b954940be2cfb3a2764cbcd9027be648e2d1672b298f9a265","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"c94d606ee25ea38bab3ba79d8f300eb8c29a33b57ad8c765c80d01759c790541","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"fbe5054058468c9f7430421cdbe92db03514f94a23840df2374edbc0ef26ff65","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"ad15e8e584544eeb2fe191af3abef38cc0f56a15aac6bd92873d95d2c75495de","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"e94b3b050b815a83c38703138461e07b62a3bbd8472f9e9321c6e85e918021b4","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"99f212eba5100b0e4dc5fcfe6c78e9f500dd5b35b4352adbf44de99888b83040","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"34693c5aac83645f8227a0ef1854d0825365beb44a539612f27f4247a3649c3d","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"2c1270470f3cc51a80769b487f2627b1e9073b2c8d9ff29183b30b6b3ef3c06c","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"ae370661ece521964de437d5d8dc118c6d5032421cf142c4d1584fe4feefd169","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"5c08da991ef5ec260b0e27c50895c420e369f8603bfec67c8be3344dd589858e","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"a92cc424f3c573125ab935523339b08c5756cace77c591126ef50cfb7f542ec8","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"7609ad90c6ae402a214d7830df05ae92a9a15a9afa7a93278495fc6b4e172c97","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"745359e85c4d1e3705b50ace4c66cbd301822127cb3e9acca9ab338fe6f7f9e3","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"1406f6a3837f3435c7eea0c6604fc940ef8760e9fad082515607d782f34abcae","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"96e0b03d16c8e0f18a4a6853348b9f712b1bd4b9645ab2d0f0714c9bdfbe1648","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"c16e9575637710b4f6f7f1717f41b745f93d447d56666a49479f5fbfbb724637","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"c213837458bf2a430e12d47cdfc01b61c8c43d52388946d9e1d91ecf68bd5da5","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"57edb6426aa2e5603b7a1cd6011473777d8d316d9289c1bb340182a7d37288f4","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"ddc14c74db0cde44935ca43de900a0cd1865111a428786a22328671c6b7d466f","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"b02bfa04c6a5d0a21101dc876a9b1db03e1bd69668236b81c55d9b5bbcf2b971","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"82bddf96ec96401b4b9b7ef44a1db6526df4596b1c2d23d7c59c99a147237637","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"b2162fb0cefce1fd71e56d015b339919f83b06e5a0440d4a6613fd631c2403b8","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"3fc1ad870b7e7fddd75dfe75c8be1b4fa2f0e8d04dfa87d4e24f8ef76c1f6fcf","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"29bce497928be544508fb9e8b34e8ea1428c38e070ec963d489090c518f90be7","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"6adcafae45d066914a826ed8ce0174f80ccbba77750a1257155b40da4100ed40","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"8dc8c6327f24f77034c16628ab1983505253f0ec57d3cd7d3b28ea5a709f357d","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"ab9ea2e6f70934991672209097071bc3f0b434b3d44897380eab37371ec7b80b","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"39c0eb5adf582143c18ffa598507e90cd1827b50dcd28b1638299e7e58db56cd","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"66c22e92d61db9bb585222c44d35012087c963908bdaddfbf60b3d864743b2ee","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"7932717e76ba1a76f59b8cb3e47d94fb0dff74dd9a24c336f3e272260983229c","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"fe996aacfe37750458f082758312cb79473ffbe200a57232cbc5871bf43237c0","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"5172fdac2126d33d4c93238706144dad587605f8b2a522b9402d9c3bbde48196","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"0c40f62cff58fbf88f17c9c8a0f99e834c2e74ceb0cd490529784602937bec2a","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"84a92874b210a4a8661d94eb8810cc46b0ec9351a5491cebd70768c1cccf72ef","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"d58431046ae1afdb8e35f7b4fe6123b336ddf0f677585d573788d5f9c473ab76","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"07a3f6139000003f91138a678e6f74a647c498e4791f68fc3f42705ddaa46217","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"4af6ceabeda7efa2819ec7b97c355e122dd47ca194c08a87f05fcc4da407b67f","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"536a3c0f74222dfa66cab03208710861c196d78fbce273b52557ce1850d74d68","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"b4ef09d41dcb94821f27a0f02567e671ca81a8a4e50dd76711fb2c035f4fd76f","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"be879f442e9b2a7c00c50fdb0a05ed3974946b446a9017ddab5f06c03e0c959a","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"5c0a2a6cd9208d0a6b2ad73611aec8d4fa0749321a5123bde4f568555f62aa63","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"b535951ae4f8ff6c03bfef4468673e1df2bef2db86627b512fe80a06025388df","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"199a1e95f589d5dece386b0468270d4e53d145956ab3cbe9bc686569bc5b067a","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"0db1e2e09bfa957ed1f3571971f6aa2dfd000bf6db8f0ca9a3b4a26b5e4f67a6","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"dbb37701c1dea8fa549574e2723413f1d8b0f30b08ecb3e9bdf2f38583fae5b4","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"3804c006fccad2a57d223691723fc2233afff020a55a074b72e8a4fd34ca3fa1","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"ab9ea2e6f70934991672209097071bc3f0b434b3d44897380eab37371ec7b80b","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"4921e14c3721b01f48c6488f108982f5897e744a72f6f5bcc4f33a54cec2b780","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"d8651081ea2a3ad9cb7e9238d921a5afc1888685ba5e8034d6d2b3ebf771a141","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"a2e7901dac82b19f522802cf0594efe7fba689bc12d6e06d7894957030921061","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"a000a2965553fa9ac5a9fe2fa530cea70d3af3a6fb5785150dd6c4cc72d0a307","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"a1bde72b7275d52b66a0dea9b126010cce8c8a502f88fc9c571dcef5ebb91712","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"65b4d53662445956a610b72afc8dc5d3d7b8652e2bcf2655e69306a2bb726d61","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"5eb9bc8901072415e9cf801b40b44ff39ca0140cf1c23a0f9e411d66bafedc31","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"a0df0d46c5a35de2d2b13db9bbbe46c1457aa902914502144eefd18bee415f96","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"355c866631a2ff2b9991170e36351ac0352f129556babdc5890ca34a55644571","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"ac160870e2cba2398a8ecaa7fe561321c2b37e14199c9058d970c30ff50f71fd","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"ee57f1a842c15658da3e801b9c53732e05dc97416f2e0b80c100d59647db59eb","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"349878fc0e298b3ae44e23b9bc9ce9dcf228d89dd3e33fafd88869b52594be20","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"1243473d35fe4537f53ff32fdaeedc0e20b4ddc97870b599f3f9067ec6a32383","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"ec7c5599afaa05f234f8be2973f634fdb90c74dd748bbe333e452219201b7e7a","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"22bcf6c43d71a817f33141ba5a73cd2a11631b06713ef009294b23d8f8246298","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"30d3a39e20b40cae5dadd459f21f174a131b3ab547d0cc7933719b723d524b49","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"d00777ef15361c9b8ab611746a911e51a34a38c9877a08ec25c09cfc53e1f194","course_id":"PHMCOL-M/PHMSCI 522","course_uid":"course_61c3f95dd92a76526910aad4","catalog_version_id":"a6216d1bd023c7aca7232d1d396524cc12bfd95e00510859f925b695ad683681","course_number":522,"subjects":["PHMCOL-M","PHMSCI"],"title":"PHARMACOLOGY II","description":"Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure.","requirements_text":"PHM SCI 521"}]